Dr. Nawal Al Kaabi
Chief Medical Officer at SEHA, United Arab Emirates
Chief Medical Officer in Sheikh Khalifa Medical City March 2017, Chair of infection Control Committee, Chair of the Clinical National Covid-19 Committee. Chair of International Patient Care Committee, DOH. Chairperson of the National Immunization Technical Advisory Group, MOH, UAE, and its vice-chairperson since 2017.
Principal Investigator of the randomized, double-blind, parallel placebo-controlled, phase III clinical trial to evaluate the safety and protective efficacy of inactivated SARS-CoV-2 vaccines in the healthy population aged 18 years old and above. Graduated MBBS from UAE University, certified Fellow in Pediatrics at the Royal College of Physicians in Canada in 2002 and Pediatric Infectious Disease in 2004.
Infection Control Fellowship at the Children’s Hospital of Eastern Ontario, University of Ottawa, Canada. American Board Certified in Pediatrics (2001), certified in global research by Harvard University (2015), certified American Board in Quality (2017), Certified Physician certificate from the American Association for Physician Leadership, USA (July 2019)
Parallel Session: The philosophy of disaster response: The Abu Dhabi module in managing COVID-19. Response, management and resilience
- 10 November, 2021
- 15:10 - 16:40